Knowledge, Attitude and Uptake of Pap Smear among Female Healthcare Professionals in a Nigerian Teaching Hospital


  • AO Olarinoye
  • MM Shiru
  • AE Ubom
  • AO Olabinjo
  • IF Abdul
  • OA Ijarotimi
  • S Nyeche
  • PC Oriji
  • L Amadi
  • JI Ikimalo



Cervical Cancer, Gynaecological malignancy, Nigeria, Papanicolaou smear, Prevention, Screening


Background: Despite the high prevalence of cervical cancer (CC) in Nigeria, the uptake of screening services, including Pap smear, remains poor, even amongst healthcare providers.

Objective: To assess Pap smear knowledge, attitude, and uptake among female healthcare professionals (FHPs).

Methods: A cross-sectional descriptive study was conducted at the University of Ilorin Teaching Hospital (UITH), Kwara State, Nigeria, using a self-administered questionnaire.

Results: A majority (343, 98.6%) of the FHPs knew Pap smear. Five (26.3%) medical laboratory scientists did not know what a Pap smear was. All the nurses, doctors, pharmacists, physiotherapists and medical social workers knew Pap smear. Only a fifth (71; 20.4%) of the FHPs had ever done a Pap smear. The most common reason cited for not having done a Pap smear was lack of time (109; 31.3%). There was a relationship between age and uptake of Pap smear (p = 0.024). Only 188 (54%) of the FHPs had ever recommended Pap smear to other women.

Conclusion: Despite the high level of knowledge of Pap smear amongst FHPs in Nigeria, attitude and uptake remain poor. There is a need for further training and education of FHPs on the benefits of CC screening to increase their uptake and improve their effectiveness in promoting positive attitudes towards CC screening and prevention in the general population.


Stewart TS, Moodley J, Walter FM. 2018. Population risk factors for late-stage presentation of cervical cancer in sub-Saharan Africa. Cancer Epidemiol 2018; 53: 81-92.

Huang HY, Tsai WC, Chou WY, Hung YC, Liu LC, Huang KF et al. Quality of life of breast and cervical cancer survivors. BMC Women's Health 2017; 17: 1-2.

Asseffa NA. Cervical cancer: Ethiopia’s outlook. J Gynecol Women's Health 2017; 5: 555660.

Adibe MO, Aluh DO. Awareness, knowledge and attitudes towards cervical cancer amongst HIV-positive women receiving care in a Tertiary Hospital in Nigeria. J Cancer Educ 2018; 33: 1189-1194.

Bisi-Onyemaechi AI, Chikani UN, Nduagubam O. Reducing incidence of cervical cancer: knowledge and attitudes of caregivers in Nigerian city to human papillomavirus vaccination. Infect Agent Cancer 2018; 13: 1-6.

Ilevbare OE, Adegoke AA, Adelowo CM. Drivers of cervical cancer screening uptake in Ibadan, Nigeria. Heliyon 2020; 6: e03505.

Olubodun T, Odukoya OO, Balogun MR. Knowledge, attitude and practice of cervical cancer prevention among women residing in an urban slum in Lagos, Southwest Nigeria. Pan Afr Med J 2019; 32: 130.

Sowemimo OO, Ojo OO, Fasubaa OB. Cervical cancer screening and practice in low resource countries: Nigeria as a case study. Trop J Obstet Gynaecol 2017; 34: 170-6.

Mahmoodi P, Fani M, Rezayi M, Avan A, Pasdar Z, Karimi E et al. Early detection of cervical cancer based on high-risk HPV DNA-based genosensors: A systematic review. Biofactors 2019; 45: 101-117.

Aral SO, Holmes KK. The epidemiology of STIs and their social and behavioural determinants: industrialised and developing countries. In: Holmes KK, Sparling PF, Stamm WE, Piot P, Wasserheit JN, Corey L, et al. (Editors). Sexually Transmitted Diseases. 4th Edition. New York: McGraw-Hill; 2008: p. 53–92.

Bruni L, Diaz M, Castellsagué M, Ferrer E, Bosch FX, de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 2010; 202: 1789-1799.

Graham JE, Mishra A. Global challenges of implementing human papillomavirus vaccines. Int J of Equity Health 2011; 10: 1.

Okonofua F. HPV vaccine and prevention of cervical cancer in Africa. Afr J Reprod Health 2007; 11: 7-12.

Ugwu EO, Obi SN, Ezechukwu PC, Okafor II, Ugwu AO. Acceptability of human papillomavirus vaccine and cervical cancer screening among female healthcare workers in Enugu, Southeast Nigeria. Niger J Clin Pract 2013; 16: 249–252.

Aboyeji PA, Ijaiya MA, Jimoh AA. Knowledge, attitude and practice of cervical smear as a screening procedure for cervical cancer in Ilorin, Nigeria. Trop J Obstet Gynaecol 2004; 21: 114‑117.

Attah D, Ochejele S, Attah M, Ochoga M. Comparison of Knowledge, Attitude and Acceptance of Cervical Cancer Screening Between Female Health and Non-Health Personnel in Jos University Teaching Hospital. J BioMed Res Clin Pract 2019; 2: 113-120.

Akokuwebe ME, Idemudia ES, Lekulo AM, Motlogeloa OW. Determinants and levels of cervical cancer screening uptake among women of reproductive age in South Africa: evidence from South Africa Demographic and health survey data, 2016. BMC Public Health 2021;21(1):1-4.

Udigwe GO. Knowledge, attitude and practice of cervical cancer screening (Pap smear) among female nurses in Nnewi, Southeastern Nigeria. Niger J Clin Pract 2006; 9: 40–43.

Akinola OI, Aimakhu CO, Ezechi OC, Fasubaa OB. Society of Obstetrics and Gynaecology of Nigeria- Clinical practice guidelines: Guidelines for the prevention of cervical cancer. Trop J Obstet Gynaecol 2018; 35: 371-376.

Oche MO, Kaoje AU, Gana G, Ango JT. Cancer of the cervix and cervical screening: Current knowledge, attitude and practices of female health workers in Sokoto, Nigeria. Int J Med Med 2013; 5: 184-190.

Anya SE, Oshi DC, Nwosu SO, Anya AE. Knowledge, attitude, and practice of female health professionals regarding cervical cancer and pap-smear. Niger J Med 2005; 14: 283-286.

Dim CC, Ekwe E, Madubuko T, Dim NR, Ezegwui HU. Improved awareness of Pap smear may not affect its use in Nigeria: a case study of female medical practitioners in Enugu, Southeastern Nigeria. Trans R Soc Trop Med Hyg 2009; 103: 852-854.

Ayinde OA, Omigbodun AO. Knowledge, attitude and practices related to prevention of cancer of the cervix among female health workers in Ibadan. J Obstet Gynaecol 2003; 23: 59-62.

Bakari M, Takai IU, Bukar M. Awareness and utilisation of Papanicolaou smear among health care workers in Maiduguri, Nigeria. Niger J Basic Clin Sci 2015; 12: 34-38.

Ijarotimi OA, Ubom AE, Olofinbiyi BA, Kuye-Kuku T, Orji EO, Ikimalo JI. COVID‐19 and obstetric practice: A critical review of the Nigerian situation. Int J Gynecol Obstet 2020; 151: 17-22.

Ubom AE, Adesunkanmi AO, Ndegbu CU, Balogun SA, Ajekwu SC, Sowemimo SO et al. Nigerian Surgical Trainees’ Work Schedule: It is Time for a Change!. World J Surg 2021; 45: 2653-2660.

Adesunkanmi AO, Ubom AE, Olasehinde O, Fasubaa OB, Ijarotimi OA, Adesunkanmi ARK et al. Impact of COVID-19 on the cost of surgical and obstetric care: experience from a Nigerian teaching hospital and a review of the Nigerian situation. Pan Afr Med J 2020; 37: 15.

Mandelblatt JS, Yabroff KR. Breast and cervical cancer screening for older women: recommendations and challenges for the 21st century. J Am Med Womens Assoc 2000; 55: 210-215.






Original Research

Most read articles by the same author(s)